BY ANJA HAUGE
-
EU Commission criticizes first US step towards tariffs on medicines
A toll on drugs would certainly have large effects for both continents, claims profession agent.
-
Major investor: Novo Nordisk’s latest move in the obesity war is “brilliant”
Competitors in between Novo Nordisk and Eli Lilly magnifies after Novo Nordisk’s excessive weight medication Wegovy has actually ended up being the medication of selection in…
-
US Secretary of Health to introduce placebo testing on vaccines
It is vague exactly how the effort will certainly be carried out.
-
Novartis to buy US biotech in billion-dollar deal
Swiss Novartis is on an acquisition spree, says the company, which is buying a US biotech company for USD 1.7bn.
-
Moderna shares fall on vaccine sales miss, delay in FDA review
The American business that takes on Danish Bavarian Nordic need to minimize its yearly expenditures by a billion quantity.
-
Bavarian Nordic receives UK approval for chikungunya vaccine
The permission puts on using the injection for teens and grownups over 12 years old.
-
Portrait: Gubra’s CEO has closed companies, secured an IPO in headwinds and landed a major deal: “Requires composure”
Throughout his occupation, Henrik Blou has actually gone to the helm of significant offers and has actually seen numerous firms dissolve. Currently he talks with MedWatch regarding…
-
France halts rollout of Valneva’s chikungunya vaccine for people over 65 years old
This occurs after 3 hospital stays, consisting of one fatality.
-
Boston Scientific expects USD 200bn tariff hit
Nonetheless, the medtech titan has actually elevated its projection for 2025.
-
Analyst predicts tablets will take a large share of the future obesity market: “The trend is definitely towards oral”
A number of firms have actually or else formerly anticipated that tablet computers will certainly play a smaller sized duty.
